RxDoctor Payments Data

Alexandria Geist, DO

Family Medicine · Jefferson City, MONPI 1417453655

Payments from drug & device makers

$1,971in general payments, 2019–2025

Across 133 payments — averaging $14.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$504
  • Novo Nordisk$300
  • Abbott$184
  • Amgen$158
  • Biohaven Pharmaceutical Holding Company Ltd.$124
  • Lilly USA, LLC$108
  • plus $593 from 21 others

What the payments were for

  • Food & beverage$1,971100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,971 in reported general payments places this provider in the 70th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$45,490
Medicare patients
195
Services billed
551

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide88$96,173
EliquisApixaban83$75,219
MounjaroTirzepatide66$73,486
JanuviaSitagliptin Phosphate61$40,672
Trelegy ElliptaFluticasone/Umeclidin/Vilanter42$35,318
FarxigaDapagliflozin Propanediol27$27,386
Breztri AerosphereBudesonide/Glycopyr/Formoterol24$23,449
RybelsusSemaglutide22$21,773
Nurtec OdtRimegepant Sulfate12$20,604
XareltoRivaroxaban16$11,893
JardianceEmpagliflozin14$10,960
LinzessLinaclotide17$9,440
Repatha SyringeEvolocumab14$7,512
SymbicortBudesonide/Formoterol Fumarate21$6,132
Fluticasone-SalmeterolFluticasone Propion/Salmeterol26$5,878

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$300$117,946110 claims
PfizerEliquis, Nurtec Odt, Abrysvo$30$100,935114 claims
Lilly USA, LLCMounjaro$108$73,48666 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$57$56,96772 claims
MerckJanuvia$16$40,67261 claims
GSKTrelegy Ellipta$14$35,31842 claims
AbbVieLinzess, Synthroid$504$12,25978 claims
Boehringer IngelheimJardiance$36$10,96014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Jefferson City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →